UMMC Clinical Research Support Program

Research Study Volunteers Needed!

Title: The Epidemiology and Pathophysiology of Kidney Disease in Heart Failure with Preserved Ejection Fraction with Obesity

You may qualify for this study if:
- Are an adult between ages of 18 and 75
- Are healthy OR overweight OR have been diagnosed with Heart Failure with Preserved Ejection Function (HFpEF)
- Do not have a history of kidney disease

Study participation will take 3 days and participants will receive a stipend. If you are interested in participating in the study, please contact Study Staff at [email protected], scan the QR code, or visit https://redcap.umc.edu/surveys/?s=P4EP9XRPRCJ7X7YA for more information on volunteering!

We in the Clinical Research Support Program are proud of the work we do to advance healthcare and make Mississippi healthier. In addition to Cathy Hudgins, our team is led by Jamie Brown who works diligently to make sure we are equipped with the tools we need to succeed, and her contributions often go unnoticed. Check out this article to get a little inside look at some of the work we do: https://www.umc.edu/news/News_Articles/2024/08/Clinical-Research.html?fbclid=IwZXh0bgNhZW0CMTEAAR1usn5jFJxVh7RmIb13h-hyhHrwxnp8vjVLLyCjONCbdADnYipMbCcO74w_aem_NWlCWFHddSkPhey4MRLgaA

That’s My Job: Clinical Research Medical science’s greatest advances are often the result of clinical trials meticulously organized on the front end by an often anonymous support staff. Those roles are often just as vital to successful patient outcomes as the names on printed publications.

The National Center for Complementary and Integrative Health and the University of Mississippi Medical Center present the Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection study to learn how Immulina™ affects the ability to “bounce back” against the flu virus.

This study will examine the effects that Immulina, a natural supplement derived from Spirulina (a type of algae), may or may not have on natural killer cells in the blood. The study is seeking to enroll a total of 472 healthy adults ages 18 and above.
Study participants will be given either Immulina™ capsules or a placebo and will be asked to take 2 capsules each morning and 2 capsules each evening. There are 12 study visits over about 5 months with blood collected via venipuncture at each visit. Study visits will take place on the UMMC 7th floor Clinical Research and Trials unit.

Compensation is provided for completed study visits.
To learn more about the Immulina-Flu study, email [email protected] or visit https://clinicaltrials.gov/ct2/show/NCT05447078....